Cargando…
SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
Background: Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited medical treatment options. We previously identified polo-like kinase 1 (PLK1) as one of most overexpressed genes in ACC; thus PLK1 represents a potential treatment target for this cancer type. Some PLK1 inhibitors ar...
Autores principales: | Smith, Gabrielle, Liang, Raimunde, Chortis, Vasileios, Khan, Sana, Lippert, Juliane, Hantel, Constanze, Altieri, Barbara, Fassnacht, Martin, Foster, Paul Alexander, Ronchi, Cristina Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208647/ http://dx.doi.org/10.1210/jendso/bvaa046.2164 |
Ejemplares similares
-
Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020) -
SUN-LB23 Translational Feasibility of Steroidogenic Factor-1 Antagonists as a Novel Targeted Therapy for Adrenocortical Cancer
por: Crowe, Paul D, et al.
Publicado: (2020) -
OR04-5 Circulating Cell-Free DNA-Based Biomarkers For Prognostication and Disease Surveillance in Adrenocortical Carcinoma
por: Altieri, Barbara, et al.
Publicado: (2022) -
SUN-LB060 Paraganglioma in Pregnancy: Challenges to Treatment
por: Diamond, Samantha, et al.
Publicado: (2019) -
Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)